Welcome to our dedicated page for Mynaric SEC filings (Ticker: MYNA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page compiles U.S. SEC filings historically associated with Mynaric AG and its former Nasdaq listing under the symbol MYNA. These documents provide a regulatory record of the company’s transition from a listed issuer with American Depository Shares to a deregistered entity following its restructuring under German law.
Key filings include a Form 25 filed by Nasdaq Stock Market LLC on June 23, 2025, which is a Notification of Removal from Listing and/or Registration under Section 12(b) of the Securities Exchange Act of 1934 for Mynaric AG’s American Depository Shares. This filing reflects the removal of the ADSs from listing on Nasdaq. Subsequently, a Form 15 filed on September 9, 2025, certifies the termination of registration of Mynaric AG’s American Depository Shares and ordinary shares under Section 12(g) and the suspension of the duty to file reports under Sections 13 and 15(d), relying on Rule 12g‑4(a)(1). The Form 15 notes an approximate number of one holder of record at the certification date.
In addition, Form 6‑K current reports furnish corporate news and ad‑hoc announcements related to Mynaric’s restructuring. A Form 6‑K dated July 28, 2025, includes an ad‑hoc announcement about capital reduction and capital increase, describing the expected reduction of share capital to zero euros, the expiry of existing shares, the exit of shareholders without compensation, and the termination of trading on the Frankfurt open market. Another Form 6‑K dated August 19, 2025, references corporate news about the completion of the StaRUG process and access to long-term funding.
Through these filings, readers can trace how Mynaric combined German StaRUG restructuring measures—such as capital reduction to zero and new share subscription by a financial creditor—with U.S. delisting and deregistration steps. Stock Titan’s interface surfaces these filings alongside AI-powered summaries that explain the purpose of each form, highlight the implications for former MYNA shareholders, and clarify changes in reporting obligations and listing status. This allows users to quickly understand how Mynaric’s regulatory profile evolved from an actively reporting foreign private issuer to a company that has terminated its Exchange Act registration for the covered securities.
Mynaric AG, a foreign private issuer based in Munich, Germany, filed a Form 6‑K for August 2025. The company reports that on August 19, 2025, it issued a corporate news release, which is furnished as Exhibit 99.1 titled “Mynaric Completes StaRUG Process and Secures Access to Long-Term Funding.” The filing is signed on behalf of Mynaric AG by its Chief Technology Officer, Joachim Horwath, and Chief Restructuring Officer, Andreas Reif.
Pacific Investment Management Company LLC filed Amendment No. 1 to its Schedule 13D on Mynaric AG to report that it now beneficially owns 0 Ordinary Shares, or 0% of that class. On August 14, 2025, as part of a StaRUG restructuring process, Mynaric’s existing share capital was reduced to zero and all outstanding Ordinary Shares were canceled for no value, including those previously held by PIMCO. The amendment also notes that, following a debt‑to‑equity swap, PIMCO is now the sole beneficial owner of the new equity of Mynaric, indicating that the company’s ownership structure has been completely reset through the restructuring.
Mynaric AG has submitted Form 25-NSE to notify its removal from listing and/or registration on the Nasdaq Stock Market LLC. The delisting affects the company's American Depository Shares (ADS).
Key details of the notification:
- Filing Date: June 28, 2025
- Commission File Number: 001-41045
- Company headquarters: Gilching, Germany
- The delisting process is being conducted pursuant to Exchange rules and requirements under 17 CFR 240.12d2-2(b)
The Form 25 was signed by Aravind Menon, Hearings Advisor, on June 23, 2025. This delisting action represents a significant change in Mynaric's market presence and accessibility to U.S. investors, as it will no longer be traded on the Nasdaq exchange.